Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AMRN Amarin Corp PLC

0,91

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:00:00

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Amarin (NASDAQ:AMRN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Amarin Charts.

Amarin (NASDAQ:AMRN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Amarin Charts.

News Amarin Corp PLC

Amarin Reports First Quarter 2024 Business Update and Financial Results
Mittwoch 1 Mai 2024 (5 Tage vor) • GlobeNewswire Inc.

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
Mittwoch 24 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Amarin Announces Results of Annual General Meeting of Shareholders
Montag 22 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
Montag 15 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
Montag 8 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
Montag 8 April 2024 (4 Wochen vor) • PR Newswire (Canada)

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
Samstag 6 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
Mittwoch 3 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
Montag 25 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Amarin Corp PLC News-Artikel

Energy Select Sector SPDR

JP Morgan Chase

Euro vs US Dollar

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen